Epredia is a global precision cancer diagnostics company working to improve patient outcomes by providing ground-breaking technologies.
Established in July 2019 through an acquisition by PHC Group from Thermo Fisher Scientific, Epredia is powered by some of the most respected names in the industry – Shandon, Richard-Allan Scientific, Microm, Menzel Gläser and others. Together these brands represent the entire histology workflow, from specimen collection to processing, sectioning to staining and advanced imaging to archiving. Visit our website to find a comprehensive offering of workflow solutions for histology, cytology, immunohistochemistry and digital pathology.
Since our humble beginnings in 1937, every product and service developed has been impacted by generations of employees who are committed to improving lives by enabling pathologists and researchers through enhancing precision cancer diagnostics.